Study of the specific activity of an innovative dosage form of a chemotherapeutic agent

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Introduction. On the basis of Sechenov University departments, an innovative antimicrobial and antiprotozoal drug – metronidazole in the form of effervescent tablets has been developed. Together with the «All-Russian research Institute of Medicinal and Aromatic plants», the antimicrobial activity of the developed instant tablets was studied. Metronidazole has been successfully used for more than 60 years to treat diseases of the gastrointestinal tract, genitourinary system; it is actively used in dental and dermatological practice. At the same time, there are currently no instant dosage forms of metronidazole on the pharmaceutical market of the Russian Federation that allow patients to use the drug for both internal and topical use.

Objective: to determine the antimicrobial activity of an experimentally developed new dosage form of metronidazole – effervescent tablets in comparison with ready-made dosage forms of metronidazole: infusion solution and tablets.

Material and methods. Metronidazole (substance), developed effervescent metronidazole tablets (composition No. 2 and No. 3), their placebo, sodium benzoate (auxiliary substance – sliding), industrially manufactured tablets and infusion solution. Determination of bacteriostatic and fungistatic activity was studied by dilution method. Pathogenic gram-positive and gram-negative bacteria, yeast-like and mycelial fungi were used. When determining the bacteriostatic activity of the studied samples, meat-peptone broth was used. When determining the fungistatic activity – a liquid Saburo medium.

Results. The data obtained indicate that all samples containing metronidazole in their composition practically coincide in antimicrobial (bacteriostatic and fungistatic) activity with each other and with the activity of the metronidazole substance included in their composition, which indirectly confirms the complete release of the substance from experimental dosage forms and the absence of formation of insoluble complexes with placebo that could inhibit the release of metronidazole.

Conclusion. The conducted studies have established the presence of antimicrobial activity in the developed effervescent metronidazole tablets.

全文:

受限制的访问

作者简介

Savva Naryshkin

Sechenov First Moscow State Medical University (Sechenov University)

Email: savva.naryshkin@gmail.com
ORCID iD: 0000-0003-1775-4805

postgraduate student, department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Ivan Krasnyuk

Sechenov First Moscow State Medical University (Sechenov University)

Email: krasnyuk.79@mail.ru
ORCID iD: 0000-0001-8557-8829

professor, doctor of pharmaceutical science, PhD, head of department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Ivan Krasnyuk

Sechenov First Moscow State Medical University (Sechenov University)

Email: krasnyuki@mail.ru
ORCID iD: 0000-0002-7242-2988

professor, doctor of pharmaceutical science, head of department of pharmaceutical technology, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Tatiana Fateeva

All-Russian research Institute of Medicinal and Aromatic plants

Email: fateeva2151@mail.ru
ORCID iD: 0000-0002-8231-0621

head of the microbiological research laboratory, leading researcher

俄罗斯联邦, st. Grina, 7/1, Moscow, 117216

Prascovia Mizina

All-Russian research Institute of Medicinal and Aromatic plants

Email: pg-mizina@vilarnii.ru

deputy director for scientific work, professor, doctor of pharmaceutical science

俄罗斯联邦, st. Grina, 7/1, Moscow, 117216

Anastasiya Belyatskaya

Sechenov First Moscow State Medical University (Sechenov University)

Email: av.beliatskaya@mail.ru
ORCID iD: 0000-0002-8214-4483

Candidate of pharmaceutical sciences, docent of department of pharmaceutical technology, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Ol'ga Stepanova

Sechenov First Moscow State Medical University (Sechenov University)

Email: o.i.nikulina@mail.ru
ORCID iD: 0000-0002-9885-3727

candidate of pharmaceutical science, docent of department of pharmacology, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Elena Smolyarchuk

Sechenov First Moscow State Medical University (Sechenov University)

Email: smolyarchuk@mail.ru
ORCID iD: 0000-0002-2615-7167

candidate of medical science, docent, head of department of pharmacology, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Ol'ga Plakhotnaia

Sechenov First Moscow State Medical University (Sechenov University)

Email: plahotnaya.o@mail.ru
ORCID iD: 0000-0001-7266-2933

candidate of chemical science, docent of department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Dmitrij Bokov

Sechenov First Moscow State Medical University (Sechenov University)

Email: fmmsu@mail.ru
ORCID iD: 0000-0003-2968-2466

candidate of pharmaceutical science, docent of department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Viktoriya Grikh

Sechenov First Moscow State Medical University (Sechenov University)

Email: viktoriya.grikh@mail.ru
ORCID iD: 0000-0003-1614-1070

candidate of pharmaceutical science, docent of department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Maria Boldina

Sechenov First Moscow State Medical University (Sechenov University)

Email: mar-usy@yandex.ru
ORCID iD: 0000-0002-1620-699X

postgraduate student, department of analytical, physical and colloid chemistry, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Olga Rastopchina

Sechenov First Moscow State Medical University (Sechenov University)

Email: rastop0309@yandex.ru
ORCID iD: 0000-0002-5443-6980

Candidate of pharmaceutical sciences, docent of department of pharmaceutical technology, Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

Ivan Bobrov

Sechenov First Moscow State Medical University (Sechenov University)

编辑信件的主要联系方式.
Email: bobrov2602@yandex.ru
ORCID iD: 0000-0001-8263-5541

student of Institute of Pharmacy named after A.P. Nelyubin

俄罗斯联邦, st. Trubetskaya, 8–2, Mosсow, 119991

参考

  1. Краснюк И.И. (мл.), Нарышкин С.Р., Беляцкая А.В., Тарасов В.В., Степанова О.И., Краснюк И.И., Грих В.В., Овсянникова Л.В., Мазяркин Е.В., Воробьев А.Н. Метронидазол - 60 лет применения. Вестник ВГУ, Серия: Химия. Биология. Фармация. 2020; 1: 82-90.
  2. Падейская Е.Н. Метронидазол - антимикробный препарат для лечения бактериальных и протозойных инфекций. Русский медицинский журнал. 2005; 13 (14): 909.
  3. Хайрутдинов В.Р. Розацеа: современные представления о патогенезе, клинической картине и лечении. Эффективная фармакотерапия. 2014; 19: 32-7.
  4. Ферубко Е.В. Многокомпонентные средства для профилактики и лечения заболеваний органов пищеварения. Разработка и регистрация лекарственных средств. 2020; 9 (3): 15-20. doi: 10.33380/2305-2066-2020-9-3-15-20.
  5. Терентьева О.А., Вайнштейн В.А., Флисюк Е.В., Генералова Ю.Э. Разработка таблеток, содержащих гигроскопичное активное вещество, с применением твердых дисперсий. Разработка и регистрация лекарственных средств. 2020; 9 (1): 23-8. doi: 10.33380/2305-2066-2020-9-1-23-28.
  6. Савельева Е.И. Современные технологии модифицированного высвобождения биологически активных веществ в фармацевтической разработке (обзор). Разработка и регистрация лекарственных средств. 2020; 9 (2): 56-66. doi: 10.33380/2305-2066-2020-9-2-56-66.
  7. Гордеева Д.С., Ситенкова (Буховец) А.В., Мустафин Р.И. Интерполиэлектролитные комплексы на основе сополимеров Eudragit® как носители для систем биоадгезивной гастроретентивной доставки метронидазола. Разработка и регистрация лекарственных средств. 2020; 9 (2): 72-6.doi: 10.33380/2305-2066-2020-9-2-72-76.
  8. Мустафин Р.И., Будников В.В., Абдуллина С.Г., Насибуллин Ш.Ф., Салеев Р.А. Поликомплексный носитель для трансбуккальной мукоадгезивной доставки метронидазола. Разработка и регистрация лекарственных средств. 2020; 9 (2): 83-90. doi: 10.33380/2305-2066-2020-9-2-83-90.
  9. Федеральное руководство по использованию лекарственных средств (формулярная система). Выпуск XVII. М.: Видокс, 2016; 1045.
  10. Государственный реестр лекарственных средств. [Электронный ресурс]. Доступно на: https://grls.rosminzdrav.ru [Accessed 20 May, 2021].
  11. Государственная фармакопея Российской Федерации. XIV-е изд. т. I, II. Москва: Научный центр экспертизы средств медицинского применения, 2018.
  12. Gajdacs M. The Concept of an Ideal Antibiotic: Implications for Drug Design. Molecules. 2019; 3; 24 (5): 892. doi: 10.3390/molecules24050892.
  13. Кашликова И.М., Беляцкая А.В., Краснюк И.И. (мл.), Краснюк И.И., Воропаева E.A., Eгорова E.A., Степанова О.И., Воробьев А.Н. Антимикробная активность нитрофурала в различных лекарственных формах. Химико-фармацевтический журнал. 2020; 54 (1): 31-4. doi: 10.30906/0023-1134-2020-54-1-31-34.
  14. Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М.: Медицина, 2005; 515-23.
  15. Миронов А.Н. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. М.: Гриф и К., 2012; 511-81.
  16. Косенкова С.И., Краснюк И.И., Краснюк (мл.) И.И., Беляцкая А.В., Степанова О.И., Tianlong Li, Фатеева Т.В., Мазяркин E.В., Новиков В.В., Корочкина Т.В. Противогрибковая активность раствора нафтифина гидрохлорида в комбинации с полиэтиленгликолями. Химико-фармацевтический журнал. 2020; 54 (3): 45-6. doi: 10.30906/0023-1134-2020-54-3-45-46.

补充文件

附件文件
动作
1. JATS XML
##common.cookie##